Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study2018-01-17T17:00:33-05:00
Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus Epstein-Barr virus and molecular mimicry in systemic lupus erythematosus2018-01-17T17:00:33-05:00
A contemporary strategy for sun exposure A contemporary strategy for sun exposure2018-01-17T17:00:33-05:00
Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage2018-01-17T17:00:33-05:00
Assessment of Circulating 25(OH)D and 1,25(OH)2D: Emergence as Clinically Important Diagnostic Tools Assessment of Circulating 25(OH)D and 1,25(OH)2D: Emergence as Clinically Important Diagnostic Tools2018-01-17T17:00:33-05:00
Sun protection and Vitamin D: Three dimensions of obfuscation Sun protection and Vitamin D: Three dimensions of obfuscation2018-01-17T17:00:25-05:00
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain2018-01-17T17:00:25-05:00
Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone Identification of High Potency Microbial and Self Ligands for a Human Autoreactive Class II–restricted T Cell Clone2018-01-17T17:00:25-05:00
Toward the Development of Rational Therapies in Multiple Sclerosis: What Is on the Horizon? Toward the Development of Rational Therapies in Multiple Sclerosis: What Is on the Horizon?2018-01-17T17:00:25-05:00
The protease inhibitor, Bowman Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis The protease inhibitor, Bowman Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis2018-01-17T17:00:21-05:00